Biopharmaceutics

Biography

Dr. Zhang obtained his MD with highest honor in 1983 and PhD in Toxicology and Occupational Epidemiology in 1988, from Shanghai Medical University (now Fudan University Shanghai Medical College), China. He completed his post-doctoral clinical pharmacology fellowship at University of Alabama School of Medicine (UAB) between 1989 and 1992. He joined UAB faculty in 1992 and moved through the ranks to Tenured Professor and Cancer Pharmacology Laboratory Director. In July 2010, he joined TTUHSC School of Pharmacy as Tenured Professor and Chair. With over 20 years of experience in the field of translational biomedical research, particularly in the area of translational medicine, cancer therapy and prevention, clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH, DoD, and other agencies. He has been invited to give more than 110 presentations for prestigious universities, institutions, and organizations. He has published more than 170 papers, 2 books, more than 45 invited reviews/book chapters, and more than 150 meeting abstracts. Dr. Zhang’s publications have been cited more than 6300 times. Dr. Zhang is a certified toxicologist by the American Board of Toxicology (D.A.B.T.) and has served on Board of Directors of ABT since 2009. He has been an FDA advisory committee member since 2003 and served as a panel member for NIH, DoD, CDC, FDA, and NIOSH and other international panels, including China’s National Nature Science Foundation (NSFC). For his outstanding contributions in sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009, a high national honor.

Research Interest

Translational medicine, cancer therapy and prevention, clinical pharmacology and therapeutics, pharmaceutical and toxicological research.